Drug-antibody pair has promising activity in non-Hodgkin lymphoma

(Dana-Farber Cancer Institute) A toxin linked to a targeted monoclonal antibody has shown "compelling" antitumor activity in patients with non-Hodgkin lymphomas who were no longer responding to treatment, according to a report from Dana-Farber Cancer Institute.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news